Scientific Director of Neuroscience at HMRI, Dr. Michael Harrington, was interviewed by Medscape regarding his recent migraine study presentation at the virtual annual meeting of the American Headache Society. The... read more →
HMRI’s Chief Science Officer and Scientific Director of Cardiovascular Research, Dr. Robert A. Kloner, talks about COVID and the safety of college football. Title: Same data. Same research. But different... read more →
Title: APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline Date: April 29, 2020 Link: https://www.nature.com/articles/s41586-020-2247-3 The APOE4 gene increases risk for Alzheimer's disease in about 15% of the population... read more →
Title: Medical Marijuana, Recreational Cannabis, and Cardiovascular Health Date: August 13, 2020 Link: https://www.practiceupdate.com/content/medical-marijuana-recreational-cannabis-and-cardiovascular-health/104835/65/2/1 This commentary reviews the recent statement from the American Heart Association that HMRI participated in, that... read more →
Title: Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association Date: August 5, 2020 Link: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000883 There has been controversy about the effects of... read more →
HMRI’s Chief Science Officer and Scientific Director of Cardiovascular Research, Dr. Robert A. Kloner, talks about the effects of marijuana on the cardiovascular system. Title: New study links marijuana to... read more →